Epidemiology

Venous thromboembolism in blood or marrow transplant recipients
Epidemiology

Venous thromboembolism in blood or marrow transplant recipients

Cancer is a well-recognized risk factor for venous thromboembolism (VTE) and several risk prediction models have been developed to identify patients at high risk. However, the majority of patients included in these studies had solid tumors, and blood or marrow transplant recipients were excluded...

Read More
Arterial thrombosis and pediatric cancer- should cancer associated pediatric stroke be studied?
Epidemiology

Arterial thrombosis and pediatric cancer- should cancer associated pediatric stroke be studied?

While knowledge of arterial thromboembolism prevalence and risk factors among adult cancer patients is currently growing, there seems to be only scarce information regarding arterial thrombosis in general or stroke in particular, among patients and survivors of pediatric cancer.

Read More
Developmental hemostasis and its relevance to pediatric thrombosis
Epidemiology

Developmental hemostasis and its relevance to pediatric thrombosis

The coagulation system of neonates and children evolves with age, as evidenced by marked physiological differences in the concentration of the majority of hemostatic proteins between children of different age groups and adults

Read More
Is thrombosis of retinal veins a marker of occult cancer?
Epidemiology

Is thrombosis of retinal veins a marker of occult cancer?

Although thrombosis of the retinal veins (either central or branch retinal vein thrombosis) is usually perceived as a rare entity, its prevalence in the general populationdoes indeed exceed that reported for venous thromboembolism.

Read More
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
Epidemiology

Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer

The authors of a recent study have taken a novel look at the impact of venous thromboembolism (VTE) among hospitalized cancer patients in the US, finding that the risk of VTE increased significantly in hospitalized patients suffering from additional major medical comorbidities and that medical costs almost doubled in hospitalized cancer patients with VTE compared to those without it.

Read More